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Introduction/DNP Final Project Overview
The population of focus is the University of Kentucky heart and lung transplant patients.
Patients eligible for heart transplants are typically in end-stage heart failure caused by viral
infections, damage to heart valves or muscle, coronary heart disease or hereditary conditions.
Lung transplant patients also have end-stage disease (ESLD) caused by conditions such as
idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, cystic fibrosis, alpha-1
antitrypsin deficiency, or pulmonary hypertension. Research over the years supports the need for
continuous psychiatric monitoring for these patients with end-stage diseases due to the higher
incidence of anxiety and depression within this population. According to Campbell and Etringer
(1999), a review of the literature suggests depression is a cause and a consequence of nonadherence in transplant patients. Non-adherence with medical treatment is the third leading
cause of rejection of organs after simple allograft rejection and systemic infection (Campbell &
Etringer, 1999, p. 59S).
Transplant Background
The United Network for Organ Sharing (UNOS) is a non-profit, scientific and educational
organization that administers the only Organ Procurement and Transplantation Network (OPTN)
in the United States. UNOS (2015) is involved in many aspects of the organ transplant and
donation process including the following:
•

Managing the national transplant waiting list, matching donors to recipients 24 hours a
day, 365 days a year;

•

Maintaining the database that contains all organ transplant data for every transplant event
that occurs in the U.S.;
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•

Bringing together members to develop policies that make the best use of the limited
supply of organs and give all patients a fair chance at receiving the organ they need,
regardless of age, sex, ethnicity, religion, lifestyle or financial/social status;

•

Monitoring every organ match to ensure organ allocation policies are followed;

•

Providing assistance to patients, family members and friends;

•

Educating transplant professionals about their important role in the donation and
transplant processes;

•

And educating the public about the importance of organ donation.

The following are examples of criteria set by UNOS for transplant candidates: age, ability of the
patient to recover, ABO type, height and weight, life support status, listing status and time on the
waiting list. Each organ type has individual criteria. For example, with heart transplantation,
candidate recipients are given one of four status levels (1A – the highest level, 1B, 2, and 7). A
matching candidate of Status 1A within the donor region, of matching ABO type, and within 500
miles will be given the highest priority, with multiple matches being ranked by time on the
waiting list. Each of those criteria will be progressively relaxed until a match is found
The OPTN Ethics Committee recognizes the difficulty applying broad measures of
adherence to accepting transplant candidates since empirical measures are limited, and medical
professionals often approach these issues subjectively. In social and medical venues, debate
continues to focus on alcoholism, drug abuse, smoking, eating disorders and other behaviors as
diseases or character flaws. Such behaviors are associated with disease processes in many
adults. The Ethics Committee has historically supported the conclusion that past behavior that
results in organ failure should not be considered a sole basis for excluding transplant candidates.
However, transplantation should be considered very cautiously for individuals who have
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demonstrated serious, consistent, and documented non-adherence in current or previous
treatment.
Adherence Background
Adherence and compliance are synonyms defined as the extent to which patients follow
the instructions they are given for prescribed treatments (Haynes, McDonald, Garg, & Montague,
2002, p. 1).

The terms are used interchangeably; however, the term adherence is intended to be

non-judgmental, a statement of fact rather than to blame of the patient, prescriber or treatment
(Haynes et al., 2002, p. 1). Causes of non-adherence include the following: problems with the
regimen such as adverse effects of medications, poor instructions, poor provider-patient
relationships, patients’ disagreement with the need for treatment and inability to pay for
treatment.
In 2010, the costs of health care in the U.S. exceeded $2.7 trillion and accounted for
17.9% of the gross domestic product (Iuga & McGuire, 2014, p. 35). According to Iuga &
McGuire (2014), the U.S. health care system wastes 20% to 30% of dollars spent. Between
$100 and $300 billion of avoidable health care cost have been attributed to non-adherence in the
U.S. annually, representing 3% to 10% of total U.S. health care cost (Iuga & McGuire, 2014, p.
37).
Many reasons exist for non-adherence to medical regimens, including problems with the
regimen (such as adverse effects); poor instructions; poor provider-patient relationship; patients’
disagreement with the need for treatment or inability to pay for it (Haynes et al., 2002, p. 2). The
most common regimens assessed for adherence include the following: medications, screening,
exercise, health behavior, appointment and diet (DiMatteo, 2004). Health behaviors,
appointment-keeping, and diet yield lower adherence averages; each is significantly lower than
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its comparison with other regimens (DiMatteo, 2004, p. 204). Methods of measuring adherence
include the following: pill count, physical test, medical record/chart, self-report, collateral report
and electronic monitoring (DiMatteo, 2004). The quantitative review by DiMatteo (2004)
determined self-reporting, collateral reporting, and medical records yield lower average
adherence scores compared to pill counting, physical tests, and electronic monitoring.
The National Center for Health and Statistics (2012) reports the U.S. spent $259 billion
on prescription drugs. According to Iuga & McGuire (2014), medication non-adherence is
widespread and varied by disease, patient characteristics, and insurance coverage, with nonadherence rates ranging from 25% to 50%. Patient non-adherence to prescribed medications is
associated with poor therapeutic outcomes, the progression of the disease, and an estimated
burden of billions per year in avoidable direct health care costs (Iuga & McGuire, 2014, p. 35).
Missed appointments are associated with an increased risk of hospitalization and
mortality (Nwabuo, Dy, Weeks, & Young, 2014, p. 1). According to a quantitative review by
Dr. DiMatteo (2004), appointment non-adherence is approximately 34.1%. Past research
indicates patients who miss appointments tend to by younger and of lower socioeconomic status
(Lacy, Paulman, Reuter, & Lovejoy, 2004, p. 541). According to Lacy et al., (2004), these
patients typically have a history of failed appointments, government-provided health benefits,
and psychosocial problems. Lacy et al., (2004) also determined longer waiting times have been
shown to be related to lower satisfaction, which, leads to less reliable appointment keeping.
The final DNP project is a compilation of my work over the last five years. I have selected these
articles because they represent my abilities to understand and apply the DNP Essentials. All of
the papers within the final DNP project address different aspects of the transplant population.
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Manuscript 1:
Patient Flow within the University of Kentucky Transplant Clinic

Lisa Yearsley, Harold Dennis, Dawn Jones, Madeleine Lansberry, and Kimberly Rolley
University of Kentucky
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Abstract
Patient wait times inversely correlate with patient satisfaction. The University of Kentucky
Transplant Clinic conducted a patient satisfaction survey, which indicated that inefficient clinic
processes are prolonging patient wait times. Transplant Clinic patients experience several
processes before rooming, which significantly contributes to their total wait time. The
Transplant Clinic established a goal of having at least 50% of patients roomed within 30 minutes
of their scheduled appointment time. Transplant Clinic audits revealed that the largest number of
patients not reaching this goal were liver transplant patients. The audit also indicated that the
period that contributed greatest to the delay in rooming was the wait time encountered after
phlebotomy. Patients were asked to arrive 60 minutes before their appointment time as part of a
new scheduling protocol. Results indicated that 75% of appointments that utilized this protocol
met the goal of being roomed within 30 minutes of appointment time. By decreasing wait time
and improving clinic flow, it is predicted that patient satisfaction will improve.
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Introduction
Patient flow logistics are an important component of a clinic’s process. For effective
scheduling, outpatient ambulatory clinic systems need to match demand with capacity, so that
resources are better utilized and patient waiting times reduced (Dhar, Michel, & Kanna, 2011;
Edward et al., 2008; Racine & Davidson, 2002). Patient waiting time and waiting room
congestion are quality indicators that are related to the efficiency of ambulatory care systems and
patient satisfaction (Camacho, Anderson, Safrit, Jones, & Hoffmann, 2006). Medical institutions
are increasingly sensitive to the impact of patient satisfaction in a competitive medical
marketplace. Patient satisfaction depends not only on the surgical outcome, but also on the
entire process from initial scheduling of the appointment to the time before the date of operation,
to the postoperative visit (Gibler, Nyswonger, Engel, Grannan, & Welling, 2011).

Background
Previous studies have identified an indirect relationship between the length of time that a
patient waits in an office and that patient’s level of satisfaction with their medical provider (Dhar
et al., 2011; Camacho et al., 2006; Gibler et al., 2011; Bleustein et al., 2014; Guglielmo,
Plesnick, Greenspan, & Sharif, 2013; Harnett, Correll, Hurwitz, Bader, & Hepner, 2010; Huang,
2013). Because satisfaction scores are reflections of the quality of care patients feel they have
received, many facilities have studied how to improve clinic flow to decrease patient wait times
and improve patient satisfaction (Dhar et al., 2011; Edward et al., 2008; Racine & Davidson,
2002; Huang, 2013). The University of Kentucky (UK) Transplant Clinic performed a patient
satisfaction survey, which identified patient waiting times as having the poorest satisfaction
score. Based on the findings of previous studies, this long wait time experienced by patients may
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not only decrease the overall efficiency of clinic processes but can potentially negatively
influence the patient experience (Dhar et al., 2011; Harnett et al., 2010). Also, research indicates
that extended waiting times also affect the patients’ perceived quality of care (Dhar et al., 2011;
Bleustein et al., 2014). Therefore, the goal of this project was to utilize the 8-step process to
improve patient flow through the clinic, the overall quality of care and patient satisfaction.
Over a 30-day period, from May 30, 2014, through June 30, 2014, the UK Transplant
Clinic performed an audit on patient flow from check-in to checkout for all patients seen in the
clinic. During this audit, 906 patients were tracked through patient check-in, registration, labs,
vital signs, and rooming. The focus of this audit was to identify the delays that contributed to
patient rooming times greater than 30 minutes from the scheduled appointment times.
The UK Transplant Clinic is divided into the following organ groups: heart and lung,
kidney and pancreas, and liver. Of the transplant clinics, the liver clinic was found to have the
greatest number of patients roomed in greater than 30 minutes from appointment time. For all
organ groups, the longest waiting period occurred between the labs station and the vital signs
station. Another trend noted was the liver clinic patients were not directed to arrive early for
their scheduled appointments.
Methods
The initial patient population consisted of patients who received pre-transplant or posttransplant care at the University of Kentucky Transplant Clinic from June 1, 2014, to June 30th,
2014. The Transplant Quality Assurance and Performance Improvement (QAPI) manager,
Jennifer Watkins, RN, CCTC, de-identified the data, removing protected health information
before releasing the data to our team of researchers. Therefore, per Institutional Review Board
protocols, patient consent was not required for this study.
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All UK Transplant Clinic appointments were audited daily as part of the clinic
performance improvement initiatives. Data for the month of June, collected in the APM and
Lobby registration systems, was utilized for this project. For each of these appointments, the
following descriptive data were collected: appointment date, organ transplant team, the reason
for appointment, and patient-provider. Additionally, numerical data was comprised of the
recorded times for the following patient checkpoints: appointment time, check-in, beginning and
completion times of registration, phlebotomy, vital signs collection, time of patient placement in
the exam room, and patient discharge time. From the 904 original appointments, all
appointments that were missing one or more descriptive or numerical data points were excluded,
leaving 465 patient encounters to be analyzed.
Using Microsoft Excel for data analysis, each appointment was evaluated as to whether it
met the clinic’s goal of patient placement in the exam room within 30 minutes of the
appointment time. Overall, 214 patients met this standard, leaving a gap of 251 patients who
failed to be roomed within 30 minutes. The organ transplant team further sorted these 251
appointments by organ group to identify which group had the greatest volume of patients not
meeting the 30-minute standard. This organ-based division revealed that ten heart patients, 45
kidney patients, 91 lung patients, and 105 liver patients did not meet the standard, identifying the
liver transplant group as the group with the greatest number of patients not meeting the standard
(See Table 1).
For the 105 appointments in the data set, the time elapsed between each checkpoint was
calculated to identify the specific point in the patient flow which contributed the greatest amount
to the overall wait time and then averaged to determine the overall delay for each point-of-
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occurrence. The greatest waiting time was found to be the period between the phlebotomy and
vital sign collection; on average this time was 44.4 minutes.
In early December 2014, our team met with the Transplant Clinic QAPI Manager and the
Transplant Clinic staff to identify possible countermeasures that would reduce the phlebotomy to
vital signs waiting time, thereby facilitating the rooming of patients within the 30-minute
standard. Creating a new protocol for scheduling appointments to allow time for the phlebotomy
process would be the most practical and efficient solution. Data analysis demonstrated the
kidney transplant team has a greater number of appointments and the largest number of patients
who meet the 30-minute standard. The new scheduling protocol for the liver team modeled the
kidney team’s schedule which requires patients to arrive at the clinic an hour before their
scheduled appointment time. Per the new protocol, as liver team patients scheduled new
appointments, they would be asked to arrive 60 minutes earlier than their appointment time.
This small cycle of change would allow time for the phlebotomy process and have patients to
roomed within 30-minutes of their scheduled appointment time.
In December 2014, a trial of this protocol was conducted. The QAPI Manager identified
four liver transplant patients who had multiple appointments scheduled within a 30-day trial
period. Front desk clerks were directed to give verbal instructions to these trial patients to arrive
60 minutes before their scheduled appointment time to allow for completion of labs. As with the
initial audit, time point data was collected via APM and Lobby registration systems. For each
encounter in which the patient did arrive at least one hour early, data was further analyzed
manually. Appointment time to rooming time was calculated and compared to the 30-minute
standard to assess the effectiveness of the countermeasure.
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Results
Of the four Transplant Clinic patients who were asked to arrive 60 minutes before their
originally scheduled appointment time, two patients refused to comply with new scheduling
protocol. The two patients that participated in the new scheduling protocol arrived 60 minutes
before their scheduled appointment time on two separate occasions for a total of four
appointments (Table 1). Three out of 4 appointment times met the standard of being roomed
within 30 minutes of their scheduled appointment times (Figure 1). As a comparison, before
implementation of the new scheduling protocol, 56 of 161 liver patients (35%) met the standard
of being roomed within 30 minutes of their appointment time.
Discussion
Summary of main findings
The purpose of this project was to identify and implement a change that would improve
patient flow through the transplant clinic, reduce patient waiting room time and congestion, and
improve overall patient satisfaction. Patient waiting time and waiting room congestion are
quality indicators related to the efficiency and patient satisfaction of ambulatory care systems
(Camacho et al., 2006; Bleustein et al., 2014; Harnett et al., 2010; Huang, 2013). A
comprehensive audit in June 2014 of the patient flow through the UK Transplant Clinic
identified the liver team as the group with the largest number of patients with a waiting time
longer than 30 minutes, and the period between labs and vital signs as the time with the greatest
average waiting time. By implementing a scheduling protocol change in December 2014, which
allotted time for lab collection and processing, participating patients were able to get their blood
drawn, and results returned from the lab to the clinic before the time that they were scheduled to
meet with their clinical provider. When they arrived 60 minutes before appointment time, our
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sample population met the standard of being roomed within 30 minutes of their scheduled
appointment time with a 75% success rate, an improvement over the 35% success rate before the
change. By decreasing wait time and waiting room congestion, it is expected that patient
satisfaction will improve.
Comparison with existing literature
The initial Transplant Clinic audit successfully identified specific points of delay that
could be addressed in quality improvement measures to improve patient satisfaction. The
process and findings of this audit were congruent with several recent studies on patient flow
(Dhar et al., 2011; Harnett et al., 2010; Racine & Davidson, 2002). This project identified
patient wait times as a measure of patient satisfaction and perceived quality of care, as similar
studies have demonstrated this to be effective means for improvement (Camacho et al., 2006;
Bleustein et al., 2014; Harnett et al., 2010). More specifically, the intervention of having
patients arrive early for pre-appointment testing was found to reduce waiting time and improve
overall patient satisfaction by 7-9% in one surgical clinic (Huang, 2013). The results are
supported by previous research that demonstrates an inverse correlation between patient wait
time and satisfaction (Camacho et al., 2006; Gibler et al., 2011; Bleustein et al., 2014; Guglielmo
et al., 2013; Harnett et al., 2010; Huang, 2013).
Limitations
The sample population was very small in comparison to the number of patients the Liver
team sees on a daily basis. Several factors limited the sample population: transplant clinic
patients are chronically ill, they have frequent appointments, and many patients travel several
hours to receive care at the UK transplant clinic. These patients are familiar with the previous

12

clinic flow, and it is imperative to give them as much notice as possible when making changes to
reduce the amount of stress they incur. The nature of the project failed to afford the time to
phase in changes at a rate comfortable for patients; during this trial, two of the four patients
asked to arrive early refused. Although the sample was small, and adherence was inconsistent,
the positive results complement the current success the kidney team has with their early arrival
protocol, suggesting that phasing in this change for the liver patients will be successful in
meeting the goal of reducing wait time and improving patient satisfaction.
Future recommendations
It is recommended that the liver team study this small cycle of change on a larger trial
population--without causing stress to current patients--by phasing in protocol changes as new
patients get referred to the clinic. Rather than phrasing the instructions as a request to arrive
early, the scheduler should inform the patient that the appointment for labs is at “X” time and the
appointment with the clinician is at “Y” time, scheduling these two events as separate entities
and prohibiting refusal by the patient. Performing patient satisfaction surveys and comparing
results among patients scheduled arrive early for their appointment and patients who do not
arrive early will provide additional data supporting these changes as a means to achieve greater
patient satisfaction. Future quality improvement projects should consider additional ways to
improve patient satisfaction, which could include streamlining lab processes to reduce time spent
in the clinic and improving consistency between scheduling protocols of the different organ
teams within the transplant clinic.
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Not Roomed
Within 30 Minutes
of Appointment
Time
25%
Roomed Within 30
Minutes of
Appointment Time
75%

Figure 1. Pie chart representing the percentage of patients roomed and not roomed within the
standard 30 minutes of appointment time after the protocol change.

16

Table 1. Breakdown of patients who met and did not meet the standard 30 minute room
time before and after implementation of new schedule protocol
Standard
Met
Before new
Scheduling
Protocol
After new
Scheduling
Protocol

56

Standard
Not Met
(Gap)
105

Number
Of
Patients
161

Percentage
Meeting
Standard
35%

3

1

4

75%
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The Importance of Psychosocial Evaluation for Heart and Lung Transplant Patients: Evidence
Review Paper

Lisa Yearsley
University of Kentucky
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Abstract
Background: The purpose of this literature review is to identify scientific evidence supporting
the need for continuous psychosocial evaluation beginning in the pre-transplant stage and
continuing through the post-transplant stage for the duration of the patient’s life.
Methods: A comprehensive search of the Cumulative Index to Nursing and Allied Health
Literature (CINAHL), COCHRANE Library, Medical Literature Analysis and Retrieval System
Online (MEDLINE), PUBMED and Center for Medicare and Medicaid approved transplant
program databases was conducted using the following combinations of keywords and terms:
Adult Heart Transplant, Adult Lung Transplant, end-stage heart disease, end-stage lung disease,
anxiety, stress, depression, psychosocial and psychological needs. Studies were selected if they
assessed the psychological and the psychosocial needs of adult heart or lung transplant patients.
Results: Ten journal articles met the inclusion criteria. The primary level of evidence was
systematic reviews of cross-sectional and correlational studies with non-independent reference
standards which is Level IV. Two of the studies were systematic reviews of cross-sectional
studies and one expert opinion study.
Conclusion: All studies were in agreement that end-stage lung disease, end-stage heart disease,
and heart and lung transplant patients are susceptible to anxiety, depression, and non-adherence.
The studies also recommended a multidisciplinary team approach with ongoing psychosocial
health assessments to improve the quality of life for this population. Finally, these studies
recommended a combination of medication and psychoeducational interventions to further
improve their quality of life for end-stage disease and transplant patients.
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Introduction
The purpose of this literature review is to determine if ongoing psychosocial assessments
improve patient outcomes and quality of life in heart and lung transplant patients. Patients with
end-stage heart and lung disease are chronically ill and frequently suffer from psychosocial
problems. Patients eligible for heart transplants are typically in end-stage heart failure caused by
viral infections, damage to heart valves and muscle, coronary heart disease or hereditary
conditions (National Institutes of Health National Heart Lung and Blood Institute Explore Heart
Transplant website, 2012). Lung transplant patients also have end-stage lung disease (ESLD)
caused by conditions such as idiopathic pulmonary fibrosis, COPD, cystic fibrosis, alpha-1
antitrypsin deficiency, or pulmonary hypertension (National Institutes of Health National Heart
Lung and Blood Institute Explore Lung website, 2011). Research over the years supports the
need for continuous psychiatric monitoring for these patients with end-stage diseases due to the
higher incidence of anxiety and depression within this population. Recommended options for
treating anxiety and depression include but not limited to the following: counseling,
pharmacological therapy, and support groups.
According to Campbell and Etringer (1999), a review of the literature suggests
depression is a cause and a consequence of non-adherence in transplant patients. Non-adherence
with medical treatment is the third leading cause of rejection of organs after simple allograft
rejection and systemic infection (Campbell & Etringer, 1999, p. 59S). A comprehensive
literature review by Fusar-Poli et al. (2007) identifies the following as having a central role in
causing depressive states in lung transplant recipients: personality disorders, coping strategies,
stressful life events, physical complications, corticosteroid medications, age, gender, and
psychosocial support. Fusar-Poli et al. (2007) concluded depression in lung transplant recipients
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is a risk factor for future non-adherence, poor quality of life, increased the risk of physical
complications and likely increased morbidity and mortality.
Methods
Data Sources
A comprehensive search of the Cumulative Index to Nursing and Allied Health Literature
(CINAHL), COCHRANE Library, Medical Literature Analysis and Retrieval System Online
(MEDLINE), PUBMED and Center for Medicare and Medicaid approved transplant program
databases was conducted using the following combinations of keywords and terms: Adult Heart
Transplant, Adult Lung Transplant, anxiety, stress, depression, psychosocial and psychological
needs. Studies were selected if they assessed the psychological and psychosocial needs of adult
heart or lung transplant patients.
Data Extraction
The search was limited to articles in the English language, published after January 1999,
which reported on assessments of and interventions for psychological needs of adult heart and
lung transplant patients. References in the extracted articles were examined for potentially
relevant articles. Studies were selected if they assessed the psychological needs of adult heart
and lung transplant patients pre-operatively and post-transplantation, and end-stage heart and
lung disease patients. Exclusion criteria included articles that focused on pediatric transplant
recipients and other transplanted organs. A total of sixteen publications were obtained from the
search of databases. After assessing titles and abstracts of the retrieved articles, ten publications
met the inclusion/exclusion criteria.
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Results
From the ten journal articles that met the inclusion/exclusion criteria, 2 are well-designed
systematic reviews, 7 are descriptive studies, and 1 is expert opinion. The Center for EvidenceBased Medicine (CEBM) grades evidence on a scale in which Level I is the strongest evidence
decreasing to Level V, the weakest evidence (See Table 1). The CEBM classifies the systematic
review as Level I evidence (See Table 1). The seven descriptive studies ranked as Level IV (See
Table 1). The Level V evidence is one expert opinion (See Table 1). The CEBM further
evaluates the levels on a scale and assigns a grade of recommendation (See Table 2). The grade
of recommendations for the articles included the following: grade A (n=2); grade C (n=7); and
grade D (n=1).
The systematic review of depression following transplantation or the efficacy and safety
of therapeutic interventions in lung transplant patients thoroughly identifies causes and
treatments in this population. This study identifies serotonin reuptake inhibitors and new
generation antidepressants as the best therapeutic choices for this group (Fusar-Poli et al., 2007,
p. 55). It also makes a point to stress the need for careful monitoring by experts due to the risk
of drug-drug interactions (Fusar-Poli et al., 2007). Complementary therapies and psychoeducational intervention also help recipients to strengthen their coping strategies, offering further
advantages after transplantation (Fusar-Poli et al., 2007, p. 55).
The Level IV evidence was primarily descriptive cross-sectional studies. These articles
further supported the same conclusions found in the systematic review. Singer et al. (2001)
wanted to identify personality styles and psychopathology in patients presenting with end-stage
lung disease (ESLD) (Singer, Ruchinskas, Riley, Broshek, & Barth, 2001, p. 1246). This study
determined separate and distinct personality styles that could affect the quality of life, the need
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for adjunct treatments, and medical adherence in individuals with ESLD (Singer et al., 2001).
According to Limbos et al., even though lung transplant recipients have better general, physical,
and psychological health than their pre-transplant counterparts, both pre- and post-transplant
patients experience impairment in several psychological functioning.
Level V evidence included expert opinions. For example, the American Heart
Association, the Heart Rhythm Society and American Association of Critical Care Nurses
endorse the need for patients with implantable cardioverter defibrillators (ICDs) to receive
education and psychiatric care to cope with the anxiety, stress and post-traumatic stress disorders
(PTSD) (Dunbar et al., 2012). ICDs are frequent in end-stage heart disease patients; therefore
assessment for anxiety, depression, and PTSD is imperative in this population. Development or
modification of coping skills in both the patient and those close to the patient would work the
best to counter depression-driven etiology of non-adherence (Campbell and Etringer, 1999).
Non-adherence in the transplant population leads to decreased quality of health and a decreased
quality of life.
Conclusion
The levels of evidence were primarily Levels IV and V and a recommendation grade of C and D.
All studies were in agreement that end-stage lung and heart disease patients and heart and lung
transplant patients are susceptible to anxiety, depression, and non-adherence. Evidence-based
practice recommends a multidisciplinary team approach with continuous psychosocial evaluation
of transplant patients. To further improve quality of life, these studies recommended a
combination of medication and psychoeducational interventions would be beneficial. This
literature review demonstrates the importance of ongoing mental health assessments to improve
the quality of life for end-stage heart and lung disease patients and transplanted patients.
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Table 1. Level of evidence grading table
Diagnosis

Level 1
Systematic review
of cross-sectional
studies

Treatments

Systematic review of
randomized trials or
n-of-1 trial

Outcome

Systematic
review of inception
cohort studies

Level 2
Systematic review of
cross-sectional
studies with
consistently applied
reference standard
and blinding
Randomized trial or
(exceptionally)
observational studies
with dramatic effect
Inception cohort
studies

Level 3
Systematic review of
nonconsecutive
studies, or studies
without consistently
applied reference
standards
Non-randomized
controlled
cohort/follow-up
study
Cohort or control arm
of randomized trial

Level 4
Systematic review of
case-control study, or
cross-sectional study
with nonindependent
reference standard
Systematic review of
case-control studies,
historically controlled
studies
Systematic review of
case series

Level 5
Opinion

Opinion

Opinion

Adapted from the Centre for Evidence-Based Medicine (CEBM) Level of Evidence March 2009

Table 2. Grades of recommendation
A
Consistent level 1 studies
B
Consistent level 2 or 3 studies or extrapolations from level 1 studies
C
Level 4 studies or extrapolations from level 2 or 3 studies
D
Level 5 evidence or troublingly inconsistent or inconclusive studies of any level
Consensus Opinion supported by entire Canadian Fibromyalgia Guidelines Committee
The level may be graded down on the basis of study quality, imprecision, indirectness, because of inconsistency between studies, or
because the absolute effect size is very small; Level may be graded up if there is a large or very large effect size.
Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A., Moschetti, I., Phillips, B., Thornton, H., Goddard,
O., Hodgkinson, M., The Oxford 2011 Table of Evidence. Oxford Centre for Evidence-Based Medicine.
http://www.cebm.net/index.aspx?o=5653
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Table 3. Summary of articles
Author/Year/Journal/Title/
Reference Information

Type of
Literature/
Design

Singer, H. K., Ruchinskas, R. A., Crosssectional
Riley, K. C., Broshek, D. K.,
survey
& Barth, J. T. (2001). The
psychological impact of endstage lung disease. CHEST,
120(4), 1246-1252. Retrieved
from
http://uky.worldcat.org.ezprox
y.uky.edu/oclc/4590203890

Dunbar, S. B., Dougherty, C. M., Systematic
Review
Sears, S. F., Carroll, D. L.,
Goldstein, N. E., Mark, D. B.,
... Zeigler, V. L. (2012).
Educational and
psychological interventions to
improve outcomes for
recipients of implantable
cardioverter defibrillators and
their families. Circulation,
126, 2146-2172.
http://dx.doi.org/10.1161/CIR.
0b013e31825d59fd

Population-specific Studies
Sampl
Purpose of Article/
e Size
Findings/
Implications
243

>5000

The purpose of this article is to elucidate personality
styles and the presence of psychopathology of in a
clinical sample of patients with ESLD presenting for a
possible lung transplant.
The majority of patients evidenced mild somatic and
depressive symptoms. Approximately one fourth of
the sample exhibited marked anxiety and mood
disturbances. A small cluster also evidenced features
consistent with an antisocial personality disorder.
Separate and distinct personality styles that could
affect the quality of life, the need for adjunct
treatments and medical adherence emerged from this
sample of individuals with ESLD.
The purpose of the review is to describe the
psychological and quality-of-life outcomes after
receipt of an ICD and describe related factors, such as
patient characteristics; (2) describe the concerns and
educational/informational needs of ICD patients and
their family members; (3) outline the evidence that
supports interventions for improving educational and
psychological outcomes for ICD patients; (4) provide
recommendations for clinical approaches for
improving patient outcomes; and (5) identify priorities
for future research in this area. The ultimate goal of
this statement is to improve the precision of
identification and care of psychosocial distress in ICD
patients to maximize the derived benefit of the ICD.
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CEBM
CEBM
Evidence
Evidence
Grade
Level
IV

C

I

A

Campbell, B., & Etringer, G. (1999).
Post-transplant quality of life
issues: depression-related
noncompliance in cardiac
transplant patients
[Supplemental material 4A].
Transplantation Proceedings,
31, 59S-60S.
http://dx.doi.org/10.1016/S00411345(99)00130-X

Descriptive,
Retrospectiv
e

Miller, M.D., M. (2002). Depression
after cardiac transplant treated
with interpersonal psychotherapy
and paroxetine. Depression after
cardiac transplant treated with
interpersonal psychotherapy and
paroxetine, 56(4), 555-61.
Stavem, K., Bjortuft, O., Lund, M. B.,
Kongshaug, K., Geiran, O., &
Boe, J. (2000). Health-related
quality of life in lung transplant
candidates and recipients.
Respiration, 67(2), 159-165.

Descriptive
case study

Bright, M. J., Craven, J. L., & Kelly,
P. J. (1990). Assessment and
management of psychosocial
stress in lung transplant
candidates. Health & Social

Descriptive,
Prospective

The study is
a crosssectional
postal
survey

Problem-specific Studies
185
The purpose is to determine to what degree unrecognized or
untreated depression causes noncompliant behavior and
subsequent allograft rejection in cardiac transplant recipients.
Our survey established that the depression-driven etiology of
non-adherence would best be countered by development or
modification of coping skills in both the patient and those
close
to the patient.
More detailed studies of depression and non-adherence
including intervention strategies are needed
to improve understanding and the impact these strategies
could have on post-transplant outcomes.
1
Discuss the treatment of a 67-year old man with no prior
history of psychiatry illness diagnosed with major depression
following heart transplantation. Psychotherapy and
paroxetine were successful in treating depression in this heart
transplant patient
These efforts may apply to other heart transplant patients
46

The objective is to compare the health-related quality of life
of lung transplant recipients with lung transplant candidates,
using lung-specific and general instruments, and to assess the
reliability and validity of these questionnaires. Patients
surviving lung transplantations can expect a considerable
improvement in most dimensions of health-related quality of
life. Lung transplant patients can expect to have
improvements in health-related quality of life
Intervention-specific Studies
40
Describe the psychosocial aspects of lung transplant and the
role of the social worker been described as it applies in this
clinical context. This assessment alerts staff to the individual
strengths and vulnerabilities of the candidates, facilitates the
team in working with individual coping styles, allows
28

IV

C

V

D

IV

C

IV

C

Work, 15(2), 125-32.
http://dx.doi.org/10.1093/hsw/15
.2.125

Evon, D. M., Burker, E. J., Galanko,
J. A., Dedert, E., & Egan, T. M.
(2010). Depressive symptoms
and mortality in lung transplant.
Clinical Transplantation, 24(5),
E201-E206.
http://dx.doi.org/10.1111/j.13990012.2010.01236.x

Descriptive,
prospective,
longitudinal
study

200

Fusar-Poli, P., Lazzaretti, M., Ceruti,
M., Hobson, R., Petrouska, K.,
Cortesi, M.,...Politi, P. (2007).
Depression after lung
transplantation: causes and
treatment. Lung, 185(2), 55-65.
http://dx.doi.org/10.1007/s00408
-006-0093-1

Systematic
review

N/A

Grandi, S., Fabbir, S., Tossani, E.,
Mangelli, L., Branzi, A., &
Mangelli, C. (2001).

Descriptive
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implementation of prophylactic interventions, and ensures
that program resources adequately meet the demands of
patients who are accepted to the waiting list. These efforts
have proven to be effective and well received with a
minimum of complications.
To determine whether depressive symptoms predicted
survival before and after lung transplantation. Pre-transplant
depressive symptoms were associated with mortality among
lung transplant candidates in an unadjusted model and a
model fit with demographics and forced expiratory volume in
one second. Depressive symptoms do not exert an
independent effect when forced expiratory vital capacity is
added. Depressive symptoms do not predict mortality after
transplant. Future studies need to determine whether pretransplant psychosocial characteristics confer a greater risk
for poorer transplant outcomes.
The purpose is to explore the causes of depression following
transplantation or the efficacy and safety of therapeutic
interventions in this patient group. Personality disorders,
coping strategies, stressful life events, physical
complications, corticosteroid medications, age, gender, and
psychosocial support all play a central role in causing
depressive states in lung
transplant recipients. Serotonin reuptake inhibitors (SSRIs)
and new-generation antidepressants (mirtazapine) represent
the best therapeutic choices for this group of patients.
Complementary therapies and psychoeducational intervention
also help recipients to strengthen their coping strategies,
offering further advantages after transplantation. This review
aimed to promote a debate between clinicians and nonpsychiatric health care workers to organize efficient health
services able to screen patients for depressive symptoms and
to refer them for appropriate treatment.
The aim of this study was to compare these new criteria
(Diagnostic Criteria for Psychosomatic Research, DCPR)
with DSM-IV in a population where a high prevalence of
29

IV

C

I

A

IV

C

Psychological evaluation after
cardiac transplantation: the
integration of different criteria.
Psychotherapy and
Psychosomatics, 70(), 176-183.
http://dx.doi.org/10.1159/000056
250
Limbos, M. M., Joyce, D. P., Chan,
C. K., & Kesten, S. (2000).
Psychological functioning and
quality of life in lung transplant
candidates and recipients*.
CHEST, 118(2), 408.

Descriptive
correlational
study
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psychological problems are expected (heart-transplanted
patients). At least one DCPR diagnosis was found in 85
(66%) patients, whereas at least one DSM diagnosis was
present in 23 (18%) patients. The joint use of DSM and
DCPR criteria was found to improve the identification of
psychological factors which could result in a worsening of
quality of life in heart-transplanted patients.
The purpose of the study is to examine the psychological
functioning and quality of life (QOL) of lung transplant
candidates and recipients. Although lung transplant
recipients have better general, physical and psychological
health than their pre-transplant counterparts, the present
research suggests that both groups experience impairment in
several areas of psychological functioning. Additional
research should be aimed at recognizing, intervening, and
improving patients’ psychological and emotional well-being

30

IV

C

Manuscript 3:
Comparison of the Stanford Integrated Psychosocial Assessment for Transplant and
UK Transplant Center Social Work and Family Risk Assessment Tools in the UK Cardiothoracic
Transplant Population

Lisa Yearsley
University of Kentucky

31

Introduction
Background and Significance
Transplant psychosocial listing criteria are not well standardized in the tools and
techniques utilized by medical providers (Maldonado et al., 2012). The United Network for
Organ Sharing (UNOS) has established minimal medical listing criteria for each organ system
(Maldonado et al., 2012). The Organ Procurement Transplant Network (OPTN) bylaws (2015)
state “all transplant programs shall identify appropriately trained individuals who are designated
members of the transplant team and have primary responsibility for coordinating the
psychosocial needs of transplant candidates, recipients, living donors and families.” The use of
assessment tools, such as the Stanford Integrated Psychosocial Assessment for Transplant
(SIPAT), not only assists clinicians in eliminating the emotional factor from the decision-making
process but also in presenting the facts during the selection process (Maldonado et al., 2012, p.
129). The function of psychosocial consultants should not be to make a determination regarding
the patient’s worthiness as a candidate, but to assist the transplant selection committee in making
the best clinical decision based on currently available data (Maldonado, 2009).
Review of Literature and Conceptual Perspective
A qualitative analysis literature review, from 1970 thru 1990 by Dew et al. (2000),
concluded the following regarding psychosocial assessments: 1.) They differ in content and
application to candidate selection; 2.) Psychosocial status pre-transplant does not consistently
affect medical outcomes post-transplant; 3.) Patients’ psychosocial status typically improves
with transplant, although difficulties are prevalent in psychological adjustment and adherence to
medical regimens; 4.) Psychiatric history can predict psychological outcomes after transplant but
does not consistently predict adherence; 5.) Social supports and coping strategies strengthen
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psychosocial outcomes; and 6.) Post-transplant psychosocial outcomes may predict physical
morbidity and mortality. Studies have demonstrated an association with the transplant
psychiatrist’s global rating of risk for post-transplant psychosocial problems that affect
management and post-transplant non-adherence and the number of rejection episodes (Shapiro,
Williams, Gelman, Foray, & Wukich, 1997). According to Campbell and Etringer (1999), a
review of the literature suggests depression is a cause and a consequence of non-adherence with
anti-rejection medications in transplant patients. Non-adherence with medical treatment is the
third leading cause of rejection of organs after simple allograft rejection and systemic infection
(Campbell & Etringer, 1999, p. 59S). Depression in transplant recipients is a risk factor for
future non-adherence, poor quality of life, physical complications, morbidity, and mortality
(Fusar-Poli et al., 2007).
There are three other standardized tools available for psychosocial assessment for
transplant patients. The PACT uses a 5-point scale for ten items and the rater’s overall
impression (Olbrisch, Levenson, & Hamer, 1989). Allowing for rater’s overall impression
defeats the attempt at objectivity (Presberg, Levenson, Olbrisch, & Best, 1995). The
Psychosocial Levels System (PLS) assesses patients on three gradations of intensity: Level 1
(mild/minimal); Level 2 (moderate); and Level 3 (severe), taking into account past psychiatric
history, quality of family and social support, prior coping history, coping with disease and
treatment, quality of affect, proneness to anticipatory problems, and mental status (Futterman,
Wellisch, Bond, & Carr, 1991, p. 177). Beyond the original paper nothing else was published
about the PLS most likely because The Transplant Evaluation Rating Scale (TERS) is a revision
of the PLS and it seems to have replaced it (Maldonado et al., 2012). TERS classifies patients’
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level of adjustment in 10 aspects of psychosocial functioning that are thought to be important in
adjusting to transplantation (Twillman, Manetto, Wellisch, & Wolcott, 1993, p. 144).
The SIPAT tool (See Appendix A) was presented to the UK transplant physicians in
January 2013 by Dr. Maldonado from Stanford University. The SIPAT tool standardizes the
psychosocial assessment evaluation process so all transplant candidates undergo the same
rigorous psychosocial scrutiny helping identify areas of strength that can be built upon, and areas
of weakness needing assistance or further consultation and treatment (Maldonado et al., 2012, p.
129). The SIPAT tool uses 18 identified risk factors divided into four domains. Based on the
assessment of these factors, the SIPAT provides an overall risk severity score for psychosocial
variables significant in predicting post-transplant behavior, psychosocial support viability and
effectiveness, treatment adherence, substance abuse, recidivism and mental health (Maldonado et
al., 2012, p. 126). Currently, the University of Kentucky (UK) Cardiothoracic Transplant Clinic
uses the UK Transplant Center Social Work and Family Risk Assessment Tool (See Appendix
B) developed by the social workers in the transplant clinic to assess the patient’s psychosocial
needs and identify areas which may lead to poor outcomes if the patient is transplanted. This
tool uses a qualitative design to the identified risk factors.
Objectives
The aim is to determine if the SIPAT tool produces highly predictive transplant
psychosocial outcomes compared to the current tool, the UK Transplant Center Social Work and
Family Risk Assessment tool, in the University of Kentucky (UK) cardiothoracic post-transplant
patient population.
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Methods and Procedures
Study Population
The UK Cardiothoracic Transplant Clinic post-transplant population is comprised of
chronically ill male and female patients with either end-stage heart or lung disease who have
received a heart or lung transplant. To retrospectively apply the SIPAT tool at the period of
transplant selection, a convenience sample of 100 electronic medical records (EMR) of
transplanted cardiothoracic patients during January 1, 2012, through September 15, 2015, was
selected. After the SIPAT tool had been applied to 100 EMRs, the chart was reviewed for the
following negative outcomes: lack of adherence, lack of stability of psychosocial support
system, recidivism of substances of abuse, the development/relapse of psychiatric problems or
graft failure. Positive outcomes are defined as the absence of these complications.
Adherence was assessed by patient’s ability to keep scheduled appointments, refill antirejection medication on time and take only medications approved by the transplant team. The
stable support system was identified by the presence of a support person post-transplant and the
support person being actively involved in patient care by ensuring the patient had appropriate
access to medical care at all times. Appropriate living space and the environment was assessed
by appropriately connected utilities. Recidivism of substances of abuse was determined by the
review of the chart for relapse of tobacco or illicit drugs. Development or relapse of psychiatric
problems was assessed by the addition of psychiatric medication prescribed to the patient posttransplant that wasn’t previously prescribed. Graft rejection was determined by biopsy per the
transplant protocol. One point was assigned to each outcome if the patient had a complication or
was non-adherent; therefore a patient could be 0 with no negative outcomes or 5 with a negative
outcome in each category.
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Data Analysis
Subgroup analysis of all results was conducted to determine if there was significant
variability in the results by demographic factors (e.g. gender, ethnicity, organ implanted, age at
the time of transplant, and distance from patient’s home to the transplant clinic). Simple linear
regression was conducted to compare the SIPAT score with the number of complications
encountered by each patient. All statistical analysis was carried out using Microsoft Excel
(Microsoft Office Home and Student 2010, Version 14.0.7166.5000).
Results
A total of 105 charts were reviewed, with five charts removed because the patients did
not follow up postoperatively at the UK Cardiothoracic Transplant Clinic and outcomes were
unable to be assessed (See Table 1). The group was comprised of (n=52) heart transplant
patients, (n=2) heart and lung transplant patients and (n=46) lung transplant patients. The selfidentified ethnicity of the group consisted of the following: 90% Caucasian; 7% AfricanAmerican/Black; 1% Hispanic; 1% Asian; and 1% Biracial. In eighty percent of the charts
reviewed the patient was living, and 20% were deceased. The mean age at the time of transplant
was 49.4 (SD=15.7) years. The distance the patient lived from the UK Transplant Clinic was a
mean of 108.65 (SD=146.1) miles.
The mean SIPAT score was 15.9 (SD=13.3) with an average number 1.97 (SD=1.37)
negative outcomes. The regression analysis for this study indicates a significant moderate
positive correlation (r = 0.52) between the SIPAT scores and the number of negative outcomes
patients will experience post-transplant (See Figure 1.) In the simple linear regression analysis,
SIPAT score was a significant predictor of the number of negative outcomes (b=.054; p< .0001).
The SIPAT score explained 27% of the variability in the number of negative outcomes in post-
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transplant patients. Furthermore, based on the listing criteria set forth by the SIPAT tool, 37% of
the patients had absolute contraindications to listing the patients for a transplant. Based on their
psychosocial assessments these patients would not have been transplanted until the
contraindications had been addressed adequately.
Discussion
The SIPAT had only been studied in Stanford’s transplant population. This study
validates the tool within the UK Cardiothoracic Transplant population because it shows a
correlation between the number of post-transplant negative outcomes and the SIPAT score. The
SIPAT tool is quantitative, and this provides the committee with a visual of predicted posttransplant negative outcomes. Both tools provide an opportunity to develop interventions to
prevent negative outcomes.
Current recommendations set forth by UNOS and OPTN include comprehensive medical
evaluation and a psychosocial assessment (Maldonado et al., 2012). The data collected by the
UK Transplant Center Social Work and Family Risk Assessment Tool is the same data gathered
in the SIPAT tool. However, the UK Transplant Center Social Work and Family Risk
Assessment Tool do not assign a numerical value to the data, and it does not have clear
guidelines for listing criteria. The data in this study confirms the SIPAT scores were highly
predictive of the transplant patients’ psychosocial outcomes. These findings are consistent with
the original study performed by Stanford (Maldonado et al., 2012).
Limitations of the Project
The SIPAT tool is designed for prospective assessment of patients; however, the time
constraints of the project prevented this type of study. Retrospectively using the tool allowed
assessment of its usefulness in this population without having to wait extended periods of time
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while patients on the waiting list are transplanted and eventual outcomes presented. The original
study had four reviewers, and they were able to evaluate inter-rater reliability compared to this
study with one reviewer of the charts. The Stanford study included heart, lung and liver
transplant patients. The instrument was limited to historical data contained within the patient’s
chart rather than having the opportunity to perform the exam on a live patient. Stanford was
already utilizing a quantitative tool, so there was a comparison of scores between the tools. UK’s
tool is qualitative, and a direct comparison cannot be made with the SIPAT tool. Finally, it cannot
be determined if patient outcomes would be affected by the application of strengths or
interventions for weaknesses.
Conclusion
The application of a standardized psychosocial assessment tool that utilizes a weighted
value to each identified risk factors for transplant outcomes demonstrated its strength to identify
patients who are at risk for negative outcomes after the transplant. The SIPAT scores were
found to be highly predictive of the psychosocial outcomes in the UK cardiothoracic transplant
population. Utilization of a standardized tool will allow for the development of interventions
directed at improving the patient’s candidacy (Maldonado et al., 2012, p. 130). Further study is
recommended utilizing additional people to review charts to determine inter-rater reliability
along with applying the tool in a prospective method to determine if patient outcomes improve
with interventions.
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Table 1. Demographic characteristics of study participants
Organs
Heart
Heart and Lung
Lung

n=100(%)
52 (52%)
2 (2%)
46 (46%)

Gender
Male
Female

67 (67%)
43 (43%)

Ethnicity
African-American/Black
Asian
Biracial
Caucasian
Hispanic

7 (7%)
1 (1%)
1 (1%)
90 (90%)
1 (1%)

Mortality
Living
Deceased

80 (80%)
20 (20%)

Average age of patient

49.4 years

Average distance from the UK Transplant
Clinic

108.65 miles
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Figure 1. Regression analysis of SIPAT scores vs. # of negative outcomes
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DNP Final Project Report Conclusions
According to UNOS (2015), approximately 120,152 people need a lifesaving organ
transplant. An active transplant candidate is eligible to be considered for organ offers at any
given point in time. Of the approximate 120,000 people, 77,353 people are active waiting list
candidates. From January through June 2016, 16,445 organ transplants have been performed
with 7,764 total donors (United Network for Organ Sharing, 2015). As medical advances
continue, people will continue living longer with comorbidities and the transplant candidate
waiting list will continue to grow. Therefore, it is obvious the availability of organs is low, and
the demand is high.
Research has demonstrated the importance of continued assessment of psychosocial
needs to minimize non-adherence in chronically ill patients. Standardizing psychosocial
assessment tool criteria will help to quickly identify areas for potentially negative outcomes in
end-stage organ disease patients and transplant patients. Qualitative tools collect verbal data
which is analyzed and has rater bias; however, a quantitative tool will minimize bias by
presenting the data objectively.
The transplant committee is tasked with the goal to identify the most medically and
psychosocially suitable candidates due to the lack of availability of organs. Providing the
committee with a psychosocial assessment tool which was developed on evidence-based
practices will ensure the best candidates are selected.
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